全文获取类型
收费全文 | 274篇 |
免费 | 14篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 12篇 |
妇产科学 | 7篇 |
基础医学 | 33篇 |
口腔科学 | 7篇 |
临床医学 | 37篇 |
内科学 | 40篇 |
皮肤病学 | 9篇 |
神经病学 | 5篇 |
特种医学 | 42篇 |
外科学 | 31篇 |
综合类 | 30篇 |
预防医学 | 11篇 |
眼科学 | 4篇 |
药学 | 5篇 |
中国医学 | 6篇 |
肿瘤学 | 8篇 |
出版年
2022年 | 1篇 |
2021年 | 8篇 |
2020年 | 5篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2015年 | 5篇 |
2014年 | 11篇 |
2013年 | 11篇 |
2012年 | 8篇 |
2011年 | 3篇 |
2010年 | 12篇 |
2009年 | 8篇 |
2008年 | 9篇 |
2007年 | 16篇 |
2006年 | 13篇 |
2005年 | 12篇 |
2004年 | 14篇 |
2003年 | 14篇 |
2002年 | 10篇 |
2001年 | 8篇 |
2000年 | 9篇 |
1999年 | 7篇 |
1998年 | 7篇 |
1997年 | 13篇 |
1996年 | 13篇 |
1995年 | 7篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 6篇 |
1984年 | 7篇 |
1983年 | 2篇 |
1982年 | 5篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1959年 | 1篇 |
1954年 | 1篇 |
1936年 | 1篇 |
排序方式: 共有293条查询结果,搜索用时 359 毫秒
71.
目的探讨冠心病合并糖尿病患者经皮冠状动脉介入(PCI)置入EXCEL可降解涂层雷帕霉素洗脱支架(SES)治疗的远期疗效。方法回顾性随机入选2007年1月至2007年12月住院期间冠心病合并糖尿病患者行PCI162例,并入选同时期150例无糖尿病的冠心病患者行PCI为对照组。随访5年,随访包括心绞痛复发、死亡、心肌梗死、卒中和再次血运重建的主要不良心脑血管事件。结果两组支架术成功率均为100%。随访率100%,随访5年,糖尿病组与非糖尿病组术后并发症发生率(8.8%、7.0%)、卒中发生率(3.9%、3.0%)、心源性死亡率(0.0%、0.0%)差异无统计学意义(均为P〉0.05)。再次血运重建率(30.4%、14.0%)、心绞痛复发率(42,1%、30.0%)、全因死亡率(9.8%、2.0%)糖尿病组高于非糖尿病组;但心源性病死率均为0.0%。结论选择性冠脉内置入药物洗脱支架安全,成功率高,远期疗效尚好,但糖尿病仍是远期不良预后的独立预测因素。 相似文献
72.
Hyperkalaemia is a potentially fatal disorder that demands direct treatment. The efficacy of traditional medical treatment is unpredictable, limited, of short duration or carries the risk of serious adverse events. The administration of salbutamol for hyperkalaemia in children is described in several clinical trials and case reports.
Conclusion: Salbutamol, inhaled or infused, is safe and efficacious and results in a predictable and long-lasting reduction in serum potassium. Salbutamol merits a place as the preferred medication for hyperkalaemia in children without arrhythmias. If follow-up with haemodialysis is required, the administration of salbutamol gives time to make the necessary preparations. 相似文献
Conclusion: Salbutamol, inhaled or infused, is safe and efficacious and results in a predictable and long-lasting reduction in serum potassium. Salbutamol merits a place as the preferred medication for hyperkalaemia in children without arrhythmias. If follow-up with haemodialysis is required, the administration of salbutamol gives time to make the necessary preparations. 相似文献
73.
Esra ADIŞEN Arzu ARAL Cemalettin AYBAY Mehmet Ali GÜRER 《The Journal of dermatology》2010,37(8):708-713
Although the mechanisms underlying the loss of response to infliximab are not completely understood, the formation of antibodies to infliximab (ATI) are thought to play a role. The aim of this study was to investigate the presence of ATI in psoriatic patients and to evaluate its relationship to the clinical response. Fifteen patients with psoriasis were treated with infliximab (5 mg/kg) every 8 weeks after an initial three‐dose induction treatment. An enzyme linked immunosorbent assay kit was used for analyzing the presence of ATI in sera. Effectiveness assessments included the change in Psoriasis Area and Severity Index (PASI) compared with study entry. Five (33.3%) patients developed ATI. While 5.9 ± 3.2 infliximab infusions achieved a fall in the PASI score from a mean of 20.4 ± 8.3 to 5.3 ± 2.4 in ATI‐negative patients, these values changed from 23.3 ± 11 to 10 ± 4.9 after 9 ± 5.2 infusions in ATI‐positive patients. Our results suggested that ATI measured in psoriatic patients are of clinical importance. Therefore, monitoring for the induction of ATI and rescue strategies should be developed to avoid or to maintain a delay in ATI development. 相似文献
74.
75.
109 children who survived surgical treatment for isolated pulmonary valve stenosis were followed for up to 17 years. In all the postoperative status was assessed as satisfactory. Cardiac catheterization repeated in 43 gave a resting valve gradient below 40 mmHg. The 22 children whose pulmonary valves had been excised were as healthy as the 87 who had undergone pulmonary valvotomy. Consideration was given to the desirable length of postoperative review. Except for the few children with symptoms before operation, a postoperative increase in exercise tolerance was not a feature. 相似文献
76.
PURPOSE: Litigation in obstetric and gynecologic practice has arisen as an important issue. This article aims to highlight issues related to malpractice in obstetrics and gynecology in order to point out several important aspects of medical practice, which may offer adequate professional protection. METHODS AND MATERIAL: Search of the current relevant literature. RESULTS: The four most common clinical causes of medical litigation in obstetrics and gynecology are cases involving fetal distress, uterine rupture after a vaginal birth in a woman with a previous Cesarean section, shoulder dystocia, and misdiagnosis of breast cancer. Litigation raised in most of the cases is driven by bad outcomes and not by malpractice. Additionally, both juries and the public often expect perfection as the natural result of pregnancy and any deviation from this expectation has to be the result of someone's negligence. For this reason it has become mandatory for doctors in hospitals and private practices to acquire a sufficient knowledge relating to modem management, to document carefully in writing their procedural and management plans and to become familiar with the legal aspects of medical practice. Adequate communication and a written patient's consent form are of paramount importance. CONCLUSION: Maintenance of high standards in daily practice with continuous training, clear communication and a signed Patient's Informed Consent Form along with the appropriate documentation of any procedure carried out may provide professional safety to practicing obstetricians and gynecologists in case of medical litigation. 相似文献
77.
F. GRUND H. T. SOMMERSCHILD A. WINECOFF M. R. UJHELYI T. T
NNESSEN K. A. KIRKEB
EN D. L. RUTLEN A. ILEBEKK 《Acta physiologica (Oxford, England)》1997,161(3):303-309
The importance of nitric oxide in regulating basal arterial blood flow has been examined in several different vascular beds by intra-arterial infusion of inhibitors of nitric oxide synthesis, but not in the arterial vascular bed of the liver. In the present study, NG-nitro-L -arginine (L -NNA), in a dose of 0.5 and 1.0 μmol mL?1 of hepatic arterial blood flow, was infused for 5 min into the hepatic artery in seven pigs anaesthetized with pentobarbital sodium. The haemodynamic effects observed by the first infusion were not further enhanced by the second infusion. Hepatic arterial resistance increased by 143 ± 38% and hepatic arterial blood flow declined by 38 ± 10%. A systemic effect due to `spillover' was observed, as evidenced by an increase in mean aortic blood pressure of 24 ± 4 mmHg. However, no significant increase in arterial mesenteric resistance was observed and total liver blood flow remained unchanged. Hepatic arterial vasodilation in response to occlusion of the portal vein, the arterial buffer response, remained intact after inhibition of nitric oxide synthesis. Liver lobe thickness, measured by an ultrasonic technique,was not found to change with inhibition of arterial nitric oxide synthesis, excluding a significant direct effect of arterial nitric oxide on liver capacitance. In conclusion, nitric oxide is an important regulator of hepatic arterial resistance, but does not mediate the hepatic arterial buffer response and was not found to play any significant role in total hepatic capacitance regulation. 相似文献
78.
High resolution (0.1 cM) CEPH crossover mapping panels were constructed for
chromosome 11. These panels will facilitate a transition from top- down
physical and genetic mapping strategies to integrated breakpoint mapping
strategies. Novel methods, which differ from other methods in overcoming
the limitations of incomplete heterozygosity and variable marker density,
were developed for creating the panels and integrated maps. This made it
possible to identify and sublocalize the majority of crossovers in 61
families. The panels were used to map 139 microsatellite markers. A
semi-integrated map and a fully-integrated map were constructed by
combining these data with data from CEPH 7.1 and then integrating data from
the radiation hybrid (RH) map. Genetic lengths estimated from the mapping
panels were similar to the estimates obtained when all recombinant and
non-recombinant offspring were included (189.4 cM in females and 126.1 cM
in males), indicating that genetic distances are stable at this high marker
density. The maps have a cM density of 0.62. The distance between ordered
markers is 1.39-2.92 cM depending on the criterion for order and the extent
of map integration. The 2D maps provide the resolution and flexibility
needed to enhance current applications such as positional cloning and
mapping complex disorders; while the mapping panels will greatly improve
the resolution, reliability and efficiency of future genetic mapping.
相似文献
79.
P. A. NAESS G. CHRISTENSEN K. A. KIRKEB
EN F. KIIL 《Acta physiologica (Oxford, England)》1992,145(4):369-375
Experiments were undertaken in two groups of barbiturate anaesthetized dogs to examine whether atrial natriuretic factor (ANF) exerts an effect on renal release of prostaglandin E2 (PGE2). In the first group, intravenous infusion of ANF (50 ng min-1kg-1body wt) reduced basal PGE2 release from 4.4 ± 0.8 pmol min-1to 1.8 ± 0.7 pmol min-1. In the second group, intrarenal infusion of an α-adrenoceptor agonist, phenylephrine (2.5–6.75 μg min-1), raised PGE2 release from 2.7 ± 0.5 pmol min-1to 7.5 ± 1.3 pmol min-1. During continuous α1-adrenergic stimulation, intravenous infusion of ANF (100 ng min-1kg-1body wt) reduced PGE2 release to 3.5 ± 1.0 pmol min-1. These results demonstrate that ANF reduces basal and α1-adrenergic stimulated renal PGE2 release. 相似文献
80.
天水饮治疗中风急性期疗效观察 总被引:2,自引:1,他引:1
目的 :观察中药天水饮治疗中风急性期的疗效。方法 :将 93例中风急性期患者随机分成 2组 ,2组一般治疗相同 ,治疗组 62例加用天水饮 ,病程 1周内每日 2剂 ,1周后每日 1剂。对照组 3 1例加用尼可林 0 .5 g静滴及 2周内加用 2 0 %甘露醇静滴 ,2周后加服步长新脑心通治疗。 2组治疗 3 0日后进行疗效比较。结果 :治疗组愈显率为 79.0 4 % ,病程 10日内见效率为 62 .90 % ;对照组愈显率为 5 1.61% ,病程 10日内见效率为3 8.71% ,2组比较均有显著性差异 ( χ2 =7.3 9,P<0 .0 1和 χ2 =4 .88,P<0 .0 5 )。结论 :天水饮可改善病变区脑循环 ,增强脑细胞活力 ,促进语言及肢体功能恢复 ,对中风急性期有良好的疗效 相似文献